Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Nutritional neuroscience

• Publication date

  2019-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/1028415X.2018.1461458PMID 29642764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials

  2017cited by this paper
• esveratrol lacks protective activity against acute seizures in mouse odels

  2016cited by this paper
• Resveratrol attenuates cortical neuron activity: roles of large conductance calcium-activated potassium channels and voltage-gated sodium channels

  2016cited by this paper
• Potassium Channels and Human Epileptic Phenotypes: An Updated Overview

  2016cited by this paper
• Identifying N-linked glycan moiety and motifs in the cysteine-rich domain critical for N-glycosylation and intracellular trafficking of SR-AI and MARCO

  2016cited by this paper
• Memantine delayed N‐methyl‐D‐aspartate ‐induced convulsions in neonatal rats

  2015cited by this paper
• Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus

  2015cited by this paper
• N‐methyl‐D‐aspartate receptor channel blockers prevent pentylenetetrazole‐induced convulsions and morphological changes in rat brain neurons

  2015cited by this paper
• Ketamine for the treatment of refractory status epilepticus.

  2015cited by this paper
• Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation

  2015cited by this paper
• Resveratrol and Calcium Signaling: Molecular Mechanisms and Clinical Relevance

  2014cited by this paper
• Resveratrol in epilepsy: preventive or treatment opportunities?

  2014cited by this paper
• Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy

  2014cited by this paper
• Resveratrol is Neuroprotective and Improves Cognition in Pentylenetetrazole-kindling Model of Epilepsy in Rats

  2014cited by this paper
• Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway.

  2013cited by this paper
• Control of neuronal excitability by NMDA‐type glutamate receptors in early developing binaural auditory neurons

  2012cited by this paper
• Promise of resveratrol for easing status epilepticus and epilepsy.

  2011cited by this paper
• Revisiting AMPA Receptors as an Antiepileptic Drug Target

  2011cited by this paper
• Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility

  2011cited by this paper
• The NMDA receptor complex as a therapeutic target in epilepsy: a review.

  2011cited by this paper
• Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain.

  2010cited by this paper
• Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation

  2009cited by this paper
• A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol.

  2008cited by this paper
• NMDA receptors in clinical neurology: excitatory times ahead.

  2008cited by this paper
• Inhibition of the Activity of Human Lymphocyte Kv1.3 Potassium Channels by Resveratrol

  2007cited by this paper
• Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Activity-Dependent Brain-Derived Neurotrophic Factor Gene Regulation and Limbic Epileptogenesis

  2007cited by this paper
• Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons.

  2007cited by this paper
• Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus.

  2006cited by this paper
• Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol.

  2006cited by this paper
• Trans-resveratrol, a red wine ingredient, inhibits voltage-activated potassium currents in rat hippocampal neurons.

  2005cited by this paper
• The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia.

  2005cited by this paper
• Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior

  2005cited by this paper
• Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy

  2004cited by this paper
• Structure and function of Kv4-family transient potassium channels.

  2004cited by this paper
• A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.

  2004cited by this paper
• Toluene exposure increases aminophylline-induced seizure susceptibility in mice.

  2003cited by this paper
• Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats.

  2002cited by this paper
• Protective effect of resveratrol against intracortical FeCl3-induced model of posttraumatic seizures in rats.

  2001cited by this paper
• Developmental Seizure Susceptibility of Kv1.1 Potassium Channel Knockout Mice

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Increased Hippocampal AMPA and NMDA Receptor Subunit Immunoreactivity in Temporal Lobe Epilepsy Patients

  1998cited by this paper
• Subcortical structures and pathways involved in convulsive seizure generation.

  1992cited by this paper

• The anticonvulsant activity of trace amine-associated receptor 1 (TAAR1) agonists involves GABAB receptors in mice.

  2025cites this paper
• Fluvastatin, an HMG-CoA reductase inhibitor, exerts protective effect against NMDA-induced seizure by increasing the seizure threshold and modulating membrane excitability in embryonic rat cortical neuron.

  2024cites this paper
• Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy

  2024cites this paper
• Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice

  2024influential citation
• Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence

  2024cites this paper
• Resveratrol inhibits nicotine-induced conditioned place preference in mice

  2023cites this paper
• Resveratrol impairs acquisition, reinstatement and precipitates extinction of alcohol-induced place preference in mice

  2021cites this paper
• The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.

  2020cites this paper
• Natural polyphenols in preclinical models of epilepsy

  2020cites this paper
• Characterization of Effectiveness in Concerted Ih Inhibition and IK(Ca) Stimulation by Pterostilbene (Trans-3,5-dimethoxy-4′-hydroxystilbene), a Stilbenoid

  2020cites this paper
• Effect of Seizure During Pregnancy on Seizure Susceptibility in Mouse offspring

  2019cites this paper
• Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes

  2019cites this paper
• Transcriptomic Insights into the Response of the Olfactory Bulb to Selenium Treatment in a Mouse Model of Alzheimer’s Disease

  2019cites this paper